Literature DB >> 2371598

Surveillance colonoscopy after resection for colon carcinoma.

P G Brady1, R J Straker, S Goldschmid.   

Abstract

Periodic surveillance colonoscopy was used to assess 207 asymptomatic patients with a previous history of colorectal carcinoma for 2 to 8 years. Thirty-five percent of the patients had a neoplastic lesion greater than or equal to 5 mm in diameter on initial colonoscopy. Synchronous or metachronous carcinomas were found in 11 patients; and of these second carcinomas, 82% were localized. The risk of a second carcinoma developing did not correlate with a finding of neoplastic polyps on the initial colonoscopy. Six recurrent carcinomas at the anastomosis were demonstrated. The stage of the recurrence correlated well with the stage of the primary carcinoma. Two negative colonoscopies at 1-year intervals were necessary to ensure that the colon had been cleared of neoplastic lesions. This study shows that surveillance colonoscopy in patients with a history of colorectal carcinoma has a high yield and is capable of detecting localized, asymptomatic carcinoma. After two annual colonoscopies fail to show neoplasms, surveillance colonoscopy may be scheduled at 3- to 5-year intervals.

Entities:  

Mesh:

Year:  1990        PMID: 2371598     DOI: 10.1097/00007611-199007000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Guidelines for follow up after resection of colorectal cancer.

Authors:  J H Scholefield; R J Steele
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Endoscopic follow-up after surgery for colorectal cancer.

Authors:  R J L F Loffeld
Journal:  Int J Colorectal Dis       Date:  2015-07-09       Impact factor: 2.571

3.  Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.

Authors:  Gabriela M Vargas; Kristin M Sheffield; Abhishek D Parmar; Yimei Han; Kimberly M Brown; Taylor S Riall
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.